What’s Shaping Real Estate Decisions of Life Science Companies?
According to the Massachusetts Biotechnology Council, Massachusetts is home to the largest life sciences cluster in the world. Municipalities across the Commonwealth are developing new initiatives and zoning to assist the industry in locating new research and development centers and manufacturing facilities.
Our special two-part panel discussion features speakers who are industry leaders, real estate developers who specialize in life sciences, and brokers and attorneys who work on these location decisions everyday.
“The 10-year, $1B Massachusetts Life Sciences Initiative’s incentives and programs have propelled our state to become the clear leader worldwide, not just in biopharma but in med tech too. Further, the LSI has helped expand the industry’s footprint outside of Cambridge and Boston. Worcester, Norwood, Billerica, Lexington and Woburn, among other suburbs, are now home to significant life sciences facilities including biomanufacturing plants. 18 of the top 20 global pharmaceutical companies now have a presence in Massachusetts, along with the 10 largest medical device companies in the world.” – Massachusetts Biotechnology Council
Special Introduction: Mayor Yvonne Spicer, the City of Framingham
A 32-year Framingham resident, and long-time educator, Mayor Spicer was previously the Vice President for Advocacy and Educational Partnerships at Boston’s Museum of Science. While there, Mayor Spicer was known for building partnerships in STEM education with policymakers, school districts, municipalities, business and other non-profit organizations. Prior to that, she was an administrator in both the Framingham and Newton public schools, after beginning her career as a teacher in Framingham.
Appointed to the Massachusetts Governor’s STEM Advisory Council in 2010 by Governor Deval Patrick as the co-chair of the council’s teacher development committee, she was reappointed in 2017 by Governor Charlie Baker and served on the Computer Science and Engineering and Career Pathways committees. Mayor Spicer was instrumental in establishing the 2001 Massachusetts Technology/engineering curriculum framework and the first ever Kindergarten through 12th grade assessment for technology and engineering. She has also served as an advisor/content expert to the National Governors Association. Mayor Spicer has been a consultant to numerous states on technology and engineering standards, strategic leadership development and business engagement.
Panel 1: The Brain Train – Massachusetts’ Life Sciences Corridor
Moderator: Danielle Lauzon, Partner, Goodwin
Danielle is a partner in Goodwin’s Technology & Life Sciences group and leader of the firm’s Business Law Department in Boston. From 2007 through 2012, she was recognized as Massachusetts Super Lawyer “Rising Star” for her work representing private and public companies on general corporate and securities law and mergers and acquisitions. Danielle also represents issuers in connection with the public offering and private placement of equity securities and has represented companies as well as venture capital and private equity firms in numerous venture capital financings and recapitalizations. Her representation of start-up and later stage companies spans the entire corporate life cycle. Her clients are in the life sciences and healthcare information technology services industries.
Sonal Gandhi, Senior Policy Advisor, Boston Planning & Development Agency
Sonal generates and implements policies and programs that further the Boston Planning and Development Agency’s mission of planning and guiding inclusive growth in the City of Boston. She identifies opportunities, plans and manages the formulation of economic development and planning policies for the BPDA and oversees research and analysis on proposals concerning matters of public policy. Prior to this role, Sonal oversaw the growth of the medical institution, healthcare and life-sciences sectors for the City of Boston, leading to the unprecedented growth of one of the leading healthcare and life-sciences clusters in the world. Sonal also works on strategies aiming to attract and retain major businesses in Boston. In 2008, Sonal was named one of Boston’s 40 under 40 by the Boston Business Journal.
Erin Orpik, General Manager, Related Beal
Erin is responsible for asset management of Related Beal’s Life Science portfolio. Specific areas of responsibility include property operations, financial management, leasing and marketing. Erin also leads her team in the management of all Tenant Improvement and Capital projects. Erin has over 15 years’ experience managing a variety of asset types including life science, office and retail. Prior to joining Related Beal in 2006, Erin worked in Facilities and Property Management for Meredith & Grew and Welch’s, Inc.
Lenore Rasmussen, Phd, Founder, CTO, RAS LABS
Lenore is the CTO and Founder of Ras Labs. Ras Labs produces Synthetic Muscle™, which is a class of electroactive polymer (EAP) based materials and actuators that contract and expand at low voltages (battery levels), offering a high level of control with low power consumption and with minimal heat/noise signatures. EAP contraction-expansion can be cycled repeatedly, and the amount of movement can be controlled by adjusting the voltage, which lends these materials to biofeedback. With the additional intrinsic ability to sense pressure, Ras Labs EAPs can provide for self-adjusting prosthetic liners, closed loop impact attenuating devices, or self-sensing robotic grippers/hands. Dr. Rasmussen is a recognized global leader in the EAP industry with multiple patents, peer-reviewed publications, and the book “Electroactivity in Polymeric Materials.” Her work was featured on NASA TV, which highlights Ras Labs’ goals and vision.
Juliette Reiter, Executive Managing Director, Newmark Knight Frank
Juliette joined Newmark Knight Frank in 2015 as an Executive Managing Director in the firm’s Boston office where she provides landlord and tenant leasing advisory services. Most recently, she was part of a team focused on office and laboratory leasing in the Cambridge, Route 128 West and Suburban markets at Cushman & Wakefield. With a focus on life science tenant representation assignments, Juliette works frequently with early-stage life science and medical device companies as well as on behalf of global pharmaceutical and research organizations. Her scope of experience advising office users includes professional services firms, non-profits, venture capital firms and technology companies.
Panel 2: Massachusetts Bio-Ready Communities
Moderator: Nicole Riley, Senior Attorney, Goodwin
Nicole is a senior attorney in the firm’s Real Estate Industry group with a focus on commercial leasing and transactional work. She is a member of Goodwin’s PropTech Initiative, and is a frequent panelist on commercial leasing topics, with a focus on biotech leasing. Recent representative transactions include several tenant-side biotech leases ranging from 2,500 square feet to over 270,000 square feet, for space uses including lab, vivarium and GMP facilities, as well as representation of landlords in converting office buildings to lab, in the Boston and suburban-Boston markets. Over the last several years Nicole has also represented purchasers of facilities intended for drug manufacturing in Massachusetts, Rhode Island and North Carolina.
Roberta Brien, Vice President of Projects, Worcester Business Development Corporation (WBDC)
Combining real estate with community development and planning, Roberta offers a comprehensive approach to her project management. Responsibilities include: oversight of the redevelopment of a brownfields site at 20 Franklin Street in Worcester into academic and business incubator space; project management and oversight and direction of financing including the utilization of strategies such as new market tax credits, historic tax credits, conventional financing, and state and federal grants. Roberta oversees the ongoing development of WBDC owned properties; generates and oversees fee-for-service contracts for private developers, institutions, and municipalities; assists in the creation of mixed-use developments, industrial parks and subdivision roads, expansion and relocation, and acquisition and asset management.
Teri Ford, Associate, King Street Properties
Teri joins us from King Street Properties, a privately held real estate investment management firm focused primarily on Life Science based companies and institutions. At King Street, Teri is involved in a wide range of development activities including acquisitions, financing, permitting, design, construction and leasing; most recently she was involved in the conversion of a former 100,000 SF printing facility to a premiere lab and GMP manufacturing facility in Framingham, MA. Prior to King Street, Teri was a Project Manager for Gilbane Building Company specializing in corporate interiors within the local Boston and Cambridge markets.
Patricia Nobre, Senior Design Strategist, Gensler
Patricia leads both design and research projects in education, healthcare, and life sciences, and believes in the power of design to create positive social, economic, and environmental change for all people. She brings over 15 years of experience designing projects that promote meaningful impact on multiple scales across the globe, including Latin America, the Middle East, and the United States. A seasoned facilitator and strategist, Patricia’s work is rooted in the firm belief that design is a co-creation, and she is steadfast in balancing research and data with real voices through proactive community engagement and user feedback. Drawing on advanced degrees in both architecture and education, she works with clients across industries to realize projects that further their immediate mission while preparing them to solve the big problems of the future.
Lisa Strope, Director of Research, JLL
Lisa joined JLL in July 2014 and is the Director of Research for Healthcare and Life Sciences. In this role, Lisa directs the overall research program for the two industries and strategically partners with JLL businesses and a wide range of clients to provide true market expertise. She works with JLL’s national research team to track and analyze commercial real estate markets at both the macro and micro levels and provides unique insights, comprehensive research products, and customized analysis for corporate tenant, investor, lender, and developer clients. The team leverages extensive proprietary and external sources of economic, demographic, industry, and real estate data to identify trends, forecast future conditions, and uncover risks and opportunities in the marketplace.
5:00 pm: Registration and Networking
5:30 – 7:00 pm: Program
7:00 – 8:00 pm: Reception
Thank you to our host & event sponsor: